Advantages and limitations of microarray technology in human cancer. - Wikidata - awgldk - TriplyDB

Advantages and limitations of microarray technology in human cancer.

Advantages and limitations of microarray technology in human cancer.

http://www.wikidata.org/entity/Q35551113

about

Feature extraction and signal processing for nylon DNA microarrays Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR -- how well do they correlate?Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles.Predictors of primary breast cancers responsiveness to preoperative epirubicin/cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures Systems Medicine as an Emerging Tool for Cardiovascular Genetics Meta-analysis of microarray data identifies GAS6 expression as an independent predictor of poor survival in ovarian cancer Global gene expression profiling: a complement to conventional histopathologic analysis of neoplasia.Integrated analysis of independent gene expression microarray datasets improves the predictability of breast cancer outcome A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments.Quality control in microarray assessment of gene expression in human airway epithelium Mapping eQTLs with RNA-seq reveals novel susceptibility genes, non-coding RNAs and alternative-splicing events in systemic lupus erythematosus Microarray applications in cancer research.Identification of differently expressed genes in human colorectal adenocarcinoma Understanding protein-nanoparticle interaction: a new gateway to disease therapeutics.Average rank-based score to measure deregulation of molecular pathway gene sets Insights into gene expression changes impacting B-cell transformation: cross-species microarray analysis of bovine leukemia virus tax-responsive genes in ovine B cells When tissue antigens and antibodies get along: revisiting the technical aspects of immunohistochemistry--the red, brown, and blue technique.Spatial patterns of genome-wide expression profiles reflect anatomic and fiber connectivity architecture of healthy human brain.Transcriptomic profiles differentiate normal rectal epithelium and adenocarcinoma.Methods for transcriptional profiling in plants. Be fruitful and replicate.Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus.Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling Molecular diagnosis of ATP-binding cassette transporter-related diseases.Chipping into the human genome: novel insights for transplantation.Lipidomic strategies to study structural and functional defects of ABC-transporters in cellular lipid trafficking.In praise of arrays.The glycobiology of brain tumors: disease relevance and therapeutic potential.Measuring molecular biomarkers in epidemiologic studies: laboratory techniques and biospecimen considerations.Comparison of Gene Expression Profile Between Tumor Tissue and Adjacent Non-tumor Tissue in Patients with Gastric Gastrointestinal Stromal Tumor (GIST).SILAC-Based Quantitative Proteomic Analysis Unveils Arsenite-Induced Perturbation of Multiple Pathways in Human Skin Fibroblast Cells.Multi-membership gene regulation in pathway based microarray analysis.Advantages of RNA-seq compared to RNA microarrays for transcriptome profiling of anterior cruciate ligament tears.Rapid assessment of drug response in cancer cells using microwell array and molecular imaging.Integrating RNA sequencing into neuro-oncology practice.9G DNAChip Technology: Self-Assembled Monolayer (SAM) of ssDNA for Ultra-Sensitive Detection of Biomarkers.Pair-wise comparison analysis of differential expression of mRNAs in early and advanced stage primary colorectal adenocarcinomas.Transcriptome Profiling in Systems Vascular Medicine Phosphosite-Specific Antibodies: A Brief Update on Generation and Applications.Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters.PD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancer.

P2860

Q24791649-FAA2F6D1-AED0-44C4-8D1D-2A7B28A3A5CD Q24810251-CEF4AFB2-0BF0-4FEF-A858-FB76DD4DED16 Q24810564-49858DCF-5745-4D82-A7AA-76359A3639F9 Q24812541-D215686D-87E9-430F-83C6-858165A993E2 Q28069197-7B368921-1AE4-4BED-A2D9-9D992F888848 Q30656824-190FFA88-5228-480F-8192-BEB74345FDEA Q33227605-5369D4B1-9E2D-46D2-A38F-39F145B53A55 Q33299765-FB03A0B3-AEAF-4185-8568-14B763D3EB8A Q33314438-FDC0D242-59F5-45CE-A3CC-0C4CED03DF96 Q33512143-DF4154AB-D7F2-4CEF-8BF8-2EDB47C11945 Q33614670-2C13E3FC-B65A-457D-B9E9-073255E6F81A Q33746903-C731457F-B18F-4A32-9091-1DCD53C40ECA Q33868086-C7A1DCFC-629C-4612-A9EA-5C29931C3ED6 Q34025939-5335C3FF-1283-4C50-B771-1175C7A72D89 Q34077968-0EEE5FC8-273D-4688-AF4E-F9CF0A1BA8B0 Q34353406-A95A68F9-A022-4C89-A89A-BEF467FC27E0 Q34377983-BACA2400-45A5-4DC2-B3D4-F60B0F68ECFC Q34817175-72B8FB58-6E20-42E1-AC0D-B16328AA800E Q35676166-753ECE81-5705-490E-9E5A-FE6215399A5D Q35790165-8037D830-6CC9-44A2-873E-B828A933ECA2 Q35824472-8F84F223-C247-47B3-AAD1-9C265763B70A Q36228895-7404F60F-BD4E-4359-9BD8-3C3EF37B49C3 Q36252201-D07A51B4-E4DC-428C-B3D0-0F2B3584892C Q36453368-63F3FDF2-E8A5-4C8A-B4DD-5474CD45AB6E Q36578069-E9ED1ACD-F023-4816-8881-73FB5874F2E1 Q37196276-BEC89348-929A-4C46-B5E1-7599D5A758B3 Q37615367-EAE65EA0-CC97-4A81-B00D-DCF88EDFAF87 Q38010665-0B859515-4200-4DE0-969D-E87051A0BEA3 Q38301721-C59574E2-ACA5-455D-B158-5251CA156946 Q38403001-7C4B7335-283A-4430-A8D4-8E63B6FD99D4 Q38652500-114B837B-BF0A-4F0A-8D37-8467AA612B12 Q38658133-BAB1B305-3783-4826-93F1-EADA14F20057 Q39001610-76FEF84D-A036-4F63-9746-FA427A734474 Q39459649-3F5623DE-829F-4E79-87E0-EC3B1B5C2259 Q40045582-08561B96-51B4-47C0-B11A-EB328E4FD3AD Q42270789-C06058F8-4DDD-42F5-95C2-4811C89A7662 Q42362541-E9575108-D804-4584-96EB-201CA3E046DC Q46420104-44BB0ACB-9276-4A1E-A90E-C6979FA18329 Q46803214-7A6F8576-DD00-434E-8FF2-EDFE0CD7CE28 Q47938015-33C46D5C-8409-4241-877D-78C356FB25C9

P2860

Advantages and limitations of microarray technology in human cancer.

http://www.wikidata.org/entity/Q35551113

description

2003 nî lūn-bûn

@nan

2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Advantages and limitations of microarray technology in human cancer.

@ast

Advantages and limitations of microarray technology in human cancer.

@en

type

label

Advantages and limitations of microarray technology in human cancer.

@ast

Advantages and limitations of microarray technology in human cancer.

@en

prefLabel

Advantages and limitations of microarray technology in human cancer.

@ast

Advantages and limitations of microarray technology in human cancer.

@en

P1433

Q35551113-50265A4B-81BE-4639-BFD4-BEB0B1791725

P1476

Q35551113-6F0383B0-4B40-4595-827E-58B2931EB978

P2093

Q35551113-18E9750A-3B5A-421E-B52B-5EBBE8A538C4

Q35551113-E180271A-887D-41E9-9B2C-8109B1E581C5

P2860

Q35551113-105E8270-50D3-4BB7-B4A2-27248C5C1011

Q35551113-10E51625-0304-44D2-A573-67C02E905E77

Q35551113-1A0862F2-1FED-467C-9303-B2A60DB89E96

Q35551113-38B04CEF-44B7-408B-B418-7E5EF53D7D33

Q35551113-4218A478-ECA9-45EE-AF87-D55F151B2F56

Q35551113-545A30E1-1658-412A-952A-AFF4D32C18D3

Q35551113-548A3243-9EF4-4EF7-8AF2-0D296561BE69

Q35551113-55A7E6A7-E504-4B90-9A73-7994AABC944B

Q35551113-596674ED-A6C9-472D-9C70-0702B90495A1

Q35551113-5ED5FFC9-A180-4E2E-9E8F-F44D88FE89E3

P2888

Q35551113-CED14EE3-684F-4841-9B0D-326E6AE4A452

P304

Q35551113-4B2876D3-BA2C-4390-81CD-5E6B02BB785C

P31

Q35551113-12BB8069-C147-4955-9DB2-0617AC4D8417

P356

Q35551113-B7350247-CFEA-4D7E-8803-3E3D9A5E13F3

P407

Q35551113-A48E6BFE-83A0-4F1F-8586-F5E9581F8FED

P433

Q35551113-8CA77B7A-E9AE-42AB-B305-FE37D53DF24E

P478

Q35551113-326ACD6D-4E62-48F2-B088-88FCAB33EAF0

P50

Q35551113-913E7E3C-C330-47CC-96F3-7E4BC4B13CA4

P577

Q35551113-91832552-E66C-4DF0-A810-B64DF4923120

P5875

Q35551113-D0177195-54AD-4513-AD56-CCA404542BD9

P698

Q35551113-35FB29AF-7411-40DD-8E7D-BBD0ACCE33E1

P356

P1433

P1476

Advantages and limitations of microarray technology in human cancer.

@en

P2093

Charles Zegar

http://www.w3.org/2001/XMLSchema#string

Giuseppe Russo

http://www.w3.org/2001/XMLSchema#string

P2860

STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer.

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Multiclass cancer diagnosis using tumor gene expression signatures

Diversity of gene expression in adenocarcinoma of the lung

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

P504S: a new molecular marker for the detection of prostate carcinoma.

Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions.

P2888

P304

6497-6507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1206865

http://www.w3.org/2001/XMLSchema#string

P407

P433

42

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Antonio Giordano

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9064492

http://www.w3.org/2001/XMLSchema#string

P698

14528274

http://www.w3.org/2001/XMLSchema#string